Board summary
Key figures
58,303
Registered population
55.9% aged 18–64
25.9%
Aged 65+
ICB 19.9% · England 17.9%
6.5%
Ethnic minority (non-White)
2.4% Asian · England 9.6%
35.9%
In IMD quintile 1
ICB 17.1% · England 21.0%
~19,567
Core20 residents (est.)
Resident basis; registered basis ~19,035 · see page 3
7,447
Hypertension register
+3.92% in 3 yrs · England +5.60%
495
SMI register
27.3% of Thanet's
1,412
COPD register
Reviews +8.58% in 3 yrs
Forecast to 2030
13,536
Hypertension patients, 2030
+6,089 on today
67.2%
QRISK ≥20% on statins, 2030
+2.48pp over 3 yrs
6.7%
Cancer prevalence, 2030
England 4.5%
Three things the board should see
Under-80 blood pressure control trails England.
Control is 59.5% (England 67.8%, Thanet 65.5%) and fell 1.3% over 2023 to 2025 (England +3.2%), which may reflect review or titration gaps.
Asthma reviews lag alongside high youth prescribing.
Annual review coverage is 54.8% (England 65.7%, about 1,200 unreviewed), while age 5-19 prescribing is 2,416 per 1,000 (England 1,488).
Heart failure review coverage grew faster than England.
Functional capacity reviews rose +24.2% over 2023 to 2025 (England +8.7%, Thanet +12.1%), reaching 77.7% coverage (Thanet 74.7%, ICB 75.0%).
Population, age and ethnicity
Patients aged 65+ comprise 25.9% of the list, well above England's 17.9%
Ramsgate PCN serves 58,303 registered patients, with an older demographic: 25.9% are aged 65+ (15,108 patients), above Thanet (23.6%), NHS Kent and Medway ICB (19.9%) and England (17.9%). Census usual residents are 93.5% White (Thanet 93.0%, ICB 88.6%, England 81.1%), with an ethnic minority share of 6.5%, including 2.4% Asian or Asian British. Population growth is projected at 7.8% to 2030, exceeding Thanet (6.5%), the ICB (6.0%) and England (2.3%), though projection methodology remains unverified. Note that captured individual practice lists sum to 40,666, creating an unresolved reconciliation check against the PCN total.
Age profile
65+: ICB 19.9%, England 17.9%
Ethnicity
Older people · falls rows are Thanet local-authority (LA) data, not PCN
| Measure | Local | South East | England | Period |
|---|---|---|---|---|
| Falls admissions, 65+, per 100,000 (Thanet LA) | 1,889 | 2,018 | 1,958 | 2024/25 |
| Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN) | 75.8% | 82.2% | 81.9% | 2024/25 |
| Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN) | 49.5% | 57.8% | 57.4% | 2024/25 |
| Falls admissions, 65 to 79, per 100,000 (Thanet LA) | 988 | 981 | 955 | 2024/25 |
| Falls deaths, all ages, per 100,000 (Thanet LA) | 25.4 | 14.0 | 14.8 | 2022‑24 |
Deprivation and Core20
Core20 deprivation reaches 35.9% across the PCN and varies widely between practices
Across Ramsgate PCN, 35.9% of registered patients live in Core20 areas, compared with 36.8% in Thanet, 17.1% in NHS Kent and Medway ICB, and 21.0% in England. Practice lists total 40,666 against a PCN list of 58,303. Deprivation concentration spans 25.3 pp from East Cliff Medical Practice (38.5%) to Newington Road Surgery (63.8%). Conversely, absolute volume peaks at East Cliff Medical Practice (5,900 estimated Core20 patients), compared with 4,531 at Newington Road Surgery. Targeted support requires balancing high-concentration clinical pathways with high-volume outreach across the PCN.
% of patients in IMD quintile 1, by practice
Dashed line: England 21.0% · right column: Core20 patients, registered basis
PLUS groups and inclusion health
PLUS groups and inclusion health
495
SMI register
1.22% recorded prevalence
308
Learning disability register
0.76% recorded prevalence
27
Care homes, 832 beds
In the PCN catchment
10.3%
Provide unpaid care
Thanet, Census 2021
The PCN records 308 learning disability patients (0.8% prevalence; Thanet 0.7%, ICB 0.6%, England 0.6%) and 495 severe mental illness patients (1.2%; Thanet 1.2%, ICB 0.9%, England 1.0%). Ramsgate holds 27.5% of Thanet's learning disability register and 27.3% of its SMI register, alongside 27 catchment care homes (832 beds). Higher recorded prevalence indicates sizable cohorts for annual health reviews across practices.
Severe mental illness: physical health checks
SMI prevalence is 1.2% (England 1.0%). Annual checks trail England: blood pressure reaches 75.3% (England 83.4%) and BMI reaches 71.0% (England 82.1%), falling to 64.2% at Summerhill Surgery and 64.9% at Newington Road Surgery.
Clinical focus: hypertension and lipids
Clinical focus: hypertension and lipids
7,447
Hypertension register
+3.92%
Register growth, 3 yrs
Thanet +2.67% · England +5.60%
−0.78pp
BP control, under 80
≤140/90 · +0.94pp aged 80+
+6,089
More patients by 2030
Forecast 13,536 (21.70%)
Hypertension case-finding and control
Ramsgate PCN records 18.3% hypertension prevalence (7,447 patients), above England (15.2%) and NHS Kent and Medway ICB (16.2%), though observation periods are unconfirmed. Blood pressure control trails benchmarks: 59.5% under 80 are controlled to <= 140/90 mmHg (England 67.8%, Thanet 65.5%, ICB 64.6%), falling 1.3% over three years (England +3.2%). At The Grange Practice, control reaches 50.3%. For patients aged 80+, 72.5% meet threshold (England 81.2%), while 63.7% overall are treated to target (England 70.3%). Blood pressure control remains below national and regional comparators across all cohorts, prioritising systematic recall for poorly controlled patients.
Lipids and statins
For primary prevention, 62.2% of patients with QRISK ≥ 20% receive lipid-lowering therapy, below England (63.6%) but above Thanet (61.6%) and the ICB (61.4%). For diabetes with CVD, coverage is 84.5% (England 84.4%). Primary prevention coverage slightly trails England, while secondary prevention in diabetes meets national levels.
| Measure | Items | Cost / item | ICB | England | Annual spend |
|---|---|---|---|---|---|
| Lipid-modifying, 2026 | 118,506 | £2.10 | £1.90 | £1.86 | £248,863 |
| Cardiovascular (all), 2025 | 160,810 | £3.49 | £3.57 | £3.33 | £561,227 |
In 2026, the PCN prescribed 118,506 lipid-modifying items at £2.10 per item (spend £248,863), matching Thanet (£2.10) but exceeding England (£1.86) and NHS Kent and Medway ICB (£1.90). This is £28,441 more than at England's unit cost and £23,701 more than at ICB unit cost. These figures reflect unit cost differences rather than prescribing efficiency or formulary quality.
Clinical focus: respiratory, cancer register and children
Clinical focus: respiratory, cancer register and children
Respiratory
+2.55%
Asthma reviews, PCN 3-yr % change
+4.44%
Asthma reviews, England 3-yr % change
+2.67%
Asthma prevalence, PCN 3-yr % change
Recorded COPD prevalence is 3.5% (England 1.9%, Thanet 3.2%), but annual review coverage is 66.5% (England 76.4%, Thanet 73.6%). Asthma prevalence is 7.2% (England 6.6%), while reviews reach 54.8% (England 65.7%), leaving about 1,200 asthma patients without a recorded review. Youth asthma prescribing is 2,416 per 1,000 aged 5-19 (England 1,488).
Cancer register and children's immunisation
Cancer prevalence is 4.9% (2,009 patients; England 3.8%). MMR coverage at age 5 drops 10.3 pp from dose 1 (90.5%) to dose 2 (80.2%), 14.8 pp below the 95% target. Dose drop reaches 20.7 pp at Newington Road Surgery and 11.1 pp at Summerhill Surgery. MMR dose 1 at 24 months is 82.5% (England 88.3%).
Dashed line: 95% national coverage target · solid tick: England
Early cancer diagnosis
Early cancer diagnosis
55.6%
Kent and Medway ICB, stage 1–2
55.3%
England, 2022
75%
National ambition by 2028
~1,630
Extra early-stage cases a year to reach the ambition
| Stage 1–2 share by cancer type, 2022 | Kent and Medway ICB | England | No usable stage | Staged cancers |
|---|---|---|---|---|
| Breast | 82.1% | 85.4% | 23% | 1,509 |
| Prostate | 54.4% | 53.2% | 37% | 1,435 |
| Lung | 29.4% | 33.8% | 21% | 1,109 |
| Bowel | 48.2% | 47.0% | 29% | 1,013 |
| Skin cancer | 87.5% | 87.8% | 23% | 562 |
In 2022, across NHS Kent and Medway ICB, 55.6% of staged cancers (4,661 of 8,384) were diagnosed at stage 1 or 2, in line with England (55.3%) but 19.4 pp below the 75.0% national ambition by 2028. Known stage was recorded for 63.6% of registered cancers (8,384 of 13,189), below England (67.0%). Closing the gap to the 75.0% ambition across the ICB would require approximately 1,627 additional early-stage diagnoses annually, while the ICB early-stage share rose 2.2 pp from 2013 (53.4%) to 2022. Early diagnosis remains lower for lung (29.4%) and bowel (48.2%). These system figures describe the ICB rather than PCN performance.
Cancer waits, diagnostics and community services
Cancer waits, diagnostics and community services
Cancer waits and diagnostics, Jul 2026 (provisional)
In provisional July 2026 data, East Kent Hospitals University NHS Foundation Trust achieved 70.0% on the 62-day standard (target 85.0%), below NHS Kent and Medway Integrated Care Board (75.9%), Medway NHS Foundation Trust (81.6%) and England (71.2%). On the 28-day faster diagnosis standard, the trust reached 71.3% (target 75.0%, ICB 76.8%, England 79.3%). For diagnostics in July 2026, 6+ week waits reached 47.6% for MRI, 37.4% for CT and 63.0% for non-obstetric ultrasound (England 21.4%, 9.9% and 19.6%). These provider figures reflect acute system waits rather than PCN performance.
| Pathways within standard (%) | East Kent | Mid and South Essex | Medway | Kent and Medway ICB | England |
|---|---|---|---|---|---|
| 28-day faster diagnosis (75%) | 71.28 | 67.45 | 77.77 | 76.78 | 79.32 |
| 31-day treatment (96%) | 96.67 | 81.88 | 99.62 | 95.84 | 92.50 |
| 62-day referral to treatment (85%) | 70.01 | 50.25 | 81.64 | 75.93 | 71.16 |
| Diagnostic waits over 6 weeks (%) | East Kent | Mid and South Essex | Medway | England |
|---|---|---|---|---|
| MRI | 47.58 | 23.35 | 0.68 | 21.40 |
| CT | 37.45 | 6.07 | 0.00 | 9.92 |
| Echocardiography | 14.17 | 65.05 | 36.62 | 28.48 |
| Colonoscopy | 9.58 | 64.09 | 1.88 | 30.83 |
| Gastroscopy | 22.16 | 59.76 | 3.32 | 29.02 |
| All 15 DM01 tests | 48.38 | 41.54 | 14.20 | 23.14 |
| Community services activity | Kent residents | Kent and Medway ICB |
|---|---|---|
| Care contacts | 210,170 | 254,055 |
| Referrals | 59,360 | 68,085 |
| Patients with a contact | 60,605 | 72,060 |
Community services (residents of Kent), Jun 2026 (provisional). In provisional June 2026 community services data, Thanet residents aged 65 and over accounted for 65.8% of all recorded community contacts, representing 138,250 of 210,170 total contacts. This reflects community care use among older residents across the borough, though data reflects local authority residency rather than PCN-registered activity.
Practice variation and patient experience
Patient satisfaction spans 32.7 percentage points across practices alongside widespread phone access shortfalls
In 2025/26, overall QOF achievement trailed England (92.5%) across all four practices, from 78.3% at The Grange Practice to 92.3% at Newington Road Surgery. Vaccination and immunisation achievement showed a 34.1 pp spread, from 16.8% at Summerhill Surgery to 50.8% at Newington Road Surgery (England 55.2%). QOF points reflect incentivised activity rather than population coverage.
GP Patient Survey by practice
| Practice | Responses | % in IMD Q1 | Phone easy | Request led to appt | Overall good |
|---|---|---|---|---|---|
| East Cliff | 87 | 38.5 | 45.7% | 71.9% | 87.2% |
| Newington Road | 88 | 63.8 | 32.5% | 65.0% | 64.2% |
| Summerhill Surgery | 99 | 55.4 | 33.3% | 70.4% | 63.3% |
| Grange | 117 | 43.1 | 31.6% | 58.1% | 54.5% |
| England | — | ~21 | 56.9% | 71.6% | 76.7% |
Where the PCN lags
Review gains contrast with lagging mental health checks and blood pressure control
Over three years, Ramsgate PCN trails England most on mental health physical checks and cardiovascular control. Psychosis alcohol status recording changed +0.4 pp (England +5.4 pp), mental health register BMI checks changed +0.2 pp (England +5.1 pp), and blood pressure checks fell 0.2 pp (England +4.4 pp). Blood pressure control under 80 fell 1.3% (England +3.2%), and non-frail diabetes HbA1c control changed +1.4% (England +4.4%). In contrast, heart failure reviews changed +24.2% (England +8.7%) and COPD reviews changed +8.6% (England +2.8%).
3-year change · PCN vs England
Bars show the direction and scale of relative change. Orange: PCN · Grey: England.
Alcohol record (psychosis)
BMI record (SMI)
BP check (SMI)
BP control, under 80
Diabetes HbA1c control
Heart failure reviews
COPD reviews
Cervical screening
What the data can't tell us: gaps and local assets
What the data can't tell us: gaps and local assets
| Local assets and voluntary sector | PCN | Thanet | Asset | PCN | Thanet |
|---|---|---|---|---|---|
| Care homes (catchment) | 27 (832 beds) | n/a | Schools (catchment) | 84 | n/a |
| Children's centres | 3 | 9 | Places of worship | 55 | 84 |
| Libraries | 3 | 6 | Day centres (VCS) | 9 | 14 |
| Children and young people (VCS) | 2 | 3 | Carers support groups (VCS) | 2 | 4 |
| Primary schools (LA maintained) | 13 | 16 | Primary academies | 10 | 14 |
| Special schools | 2 | 2 |
0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.
Options for the PCN
Options for the PCN
Each option in full
Option 1
Structured asthma review and prescribing recall
Asthma review coverage is 54.8% across the 2,746-patient register (Thanet 58.7%, NHS Kent and Medway ICB 60.4%, England 65.7%), leaving 1,240 patients (about 1,200) unreviewed. For discussion: run structured annual review and inhaler-prescribing recall across the 2,746-patient asthma register, offering flexible after-school slots. Moderate effort to run.
Evidence base: the annual asthma review is the process gap between the register and outcomes.
Policy anchor: Core20PLUS5 chronic respiratory disease priority.
Option 2
Hypertension recall and medicines titration
Blood pressure control under 80 is 59.5% (Thanet 65.5%, NHS Kent and Medway ICB 64.6%, England 67.8%) and 72.5% for 80+ (England 81.2%) across 7,447 register patients; at The Grange Practice under-80 control is 50.3%. Moderate effort to run.
Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.
Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).
Option 3
Combined SMI physical health check clinics
Across 495 SMI patients (1.2% prevalence), BMI recording is 71.0% (Thanet 73.6%, ICB 78.3%, England 82.1%) and BP recording is 75.3% (England 83.4%), with BMI at 64.2% at Summerhill Surgery. For discussion: introduce combined physical health check appointments and proactive outreach for non-attenders on the SMI register. Moderate effort to run.
Evidence base: the SMI register is the cohort for the annual physical health check; the alcohol record is the delivery measure for alcohol screening and brief intervention.
Policy anchor: Mental Health Investment Standard; NHS alcohol care teams and the From Harm to Hope strategy.
Provenance and audit trail
Provenance and audit trail
Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.
| Recommendation | Indicator(s) | Policy anchor | Data level |
|---|---|---|---|
| Anticipatory care capacity review (p2) | Aged 65+ | Neighbourhood health framework · NHS vaccination strategy | PCN |
| Two-track Core20 outreach (p3) | Core20 cohort (IMD quintile 1) | Core20PLUS5 · 10YHP equity test | PCN |
| Physical health check recall (p4) | SMI register with a BMI recorded in the last 12 months | MHIS · From Harm to Hope | PCN |
| Hypertension blood pressure recall (p5) | Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs) | Core20PLUS5 CVD · CVDPREVENT 2029 | PCN |
| Preschool MMR dose recall (p6) | MMR dose 2 coverage at age 5 | 10YHP sickness to prevention · 95% target | PCN |
| System early diagnosis collaboration (p7) | Cancers diagnosed at stage 1 or 2 (All cancer sites) | — | ICB |
| Telephone triage review (p9) | GPPS easy to contact the practice by phone | 10YHP, hospital to community | Practice |
| Option 1 · Structured asthma review and prescribing recall (p12) | Asthma register · Asthma: QOF prevalence · Patients with Asthma: review in the last 12 months (denominator incl. PCAs) | Core20PLUS5 respiratory | PCN |
| Option 2 · Hypertension recall and medicines titration (p12) | Hypertension register · Hypertension: QOF prevalence · Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs) | Core20PLUS5 CVD · CVDPREVENT 2029 | PCN & Practice |
| Option 3 · Combined SMI physical health check clinics (p12) | Severe mental illness register · Severe mental illness: QOF prevalence · SMI register with a BP check in the last 12 months | MHIS · From Harm to Hope | PCN & Practice |
Data sources
Data sources
Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.
| Dataset | Level | Period | Used for |
|---|---|---|---|
| Coplug indicator tables: census, deprivation and QOF measures | PCN & Practice | 2023 to 2025, projected to 2030; 2023 to 2024 | Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12 |
| MHCLG, Rough sleeping snapshot in England: autumn 2025 | Local authority | Autumn 2025 | Pages 2, 4 |
| OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) | PCN | 2024/25 | Pages 2, 4 |
| OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002) | Local authority | 2024/25; 2022-24 | Pages 2, 4 |
| ONS, Census 2021 TS039: provision of unpaid care (age-standardised) | Local authority | Census 2021 | Pages 2, 4 |
| QOF registers, prevalence and care processes (Coplug indicator tables) | Practice | 2023 to 2025, projected to 2030 | Pages 4, 5, 6, 7, 8, 10 |
| UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26 | PCN & Practice | Q1 2025/26 | Pages 4, 6 |
| UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026 | ICB | 2025/26 season to 28 Feb 2026 | Pages 4, 6 |
| NHS England, Cancer Waiting Times: July 2026 monthly time series with revisions | ICB & Provider | Jul 2026 (provisional) | Pages 7, 8 |
| NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental data | ICB & Local authority | Jun 2026 (provisional) | Pages 7, 8 |
| NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026 | Provider | Jul 2026 | Pages 7, 8 |
| National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022 | ICB | 2022 | Pages 7, 8 |
| NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted) | Practice | Survey Jan-Apr 2026 | Page 9 |
| NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domain | Practice | 2025/26 | Page 9 |
| NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domain | Practice | 2025/26 | Page 9 |
| Coplug indicator catalogue — definitions, cohorts, policy anchors | Reference | Current | Evidence-base lines, page 13 |
Methods, data-quality notes and limitations
Methods, data-quality notes and limitations
Methods
Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.
Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.
Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.
Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.
